Corey Rosen
Court Allows ESOP Valuation Case to Proceed
In Gamino v. KPC Healthcare Holdings, Inc. et al., No. 5:20-CV-01126-SB-SHK (C.D. Cal. Jan. 15, 2021), a district court allowed employees of KPC Healthcare to proceed with their lawsuit over an alleged overvaluation of the shares their ESOP purchased. The ESOP bought 100% of KPC Healthcare in a 2015 transaction. Plaintiffs allege that Alerus, the ESOP trustee, did not sufficiently question the valuation, which was 9 to 15 times higher than the price of company shares on a public market just two years before, when the company went private. The company had declining revenues during those two years, and the stock price fell after the transaction. Alerus said the complaint alleged no specific facts about its fiduciary process, but the court ruled that information and belief were sufficient at this stage of pleading to allow the case to proceed. Company defendants asked for dismissal on the grounds that their job was to appoint an independent trustee, but the court ruled their duty to monitor made them potentially liable in the transaction as well. Third, the court refused to dismiss claims against the former owner, Kali Pradip Chaudhuri, on the grounds that he knew the price he was receiving might be excessive and thus could be deemed a fiduciary. Finally, the court denied a motion to dismiss a claim that participants as plaintiffs should have been able to see the valuation report. The court’s language, if a trial court agrees, could imply that participants in any ESOP have a right to see the report.